BACKGROUND: Clinic-based blood pressure (CBP) has been the default approach for the diagnosis of hypertension, but patients may be misclassified because of masked hypertension (false negative) or 'white coat' hypertension (false positive). The incorporation of other diagnostic modalities, such as home blood pressure monitoring (HBPM) and ambulatory blood pressure monitoring (ABPM), holds promise to improve diagnostic accuracy and subsequent treatment decisions. MATERIALS AND METHODS: We reviewed the literature on the costs and cost-effectiveness of adding HBPM and ABPM to routine blood pressure screening in adults. We excluded letters, editorials, and studies of pregnant and/or pre-eclamptic patients, children, and patients with specific conditions (e.g. diabetes). RESULTS: We identified 14 original, English language studies that included cost outcomes and compared two or more modalities. ABPM was found to be cost saving for diagnostic confirmation following an elevated CBP in six studies. Three of four studies found that adding HBPM to an elevated CBP was also cost-effective. CONCLUSION: Existing evidence supports the cost-effectiveness of incorporating HBPM or ABPM after an initial CBP-based diagnosis of hypertension. Future research should focus on their implementation in clinical practice, long-term economic values, and potential roles in identifying masked hypertension.
BACKGROUND: Clinic-based blood pressure (CBP) has been the default approach for the diagnosis of hypertension, but patients may be misclassified because of masked hypertension (false negative) or 'white coat' hypertension (false positive). The incorporation of other diagnostic modalities, such as home blood pressure monitoring (HBPM) and ambulatory blood pressure monitoring (ABPM), holds promise to improve diagnostic accuracy and subsequent treatment decisions. MATERIALS AND METHODS: We reviewed the literature on the costs and cost-effectiveness of adding HBPM and ABPM to routine blood pressure screening in adults. We excluded letters, editorials, and studies of pregnant and/or pre-eclamptic patients, children, and patients with specific conditions (e.g. diabetes). RESULTS: We identified 14 original, English language studies that included cost outcomes and compared two or more modalities. ABPM was found to be cost saving for diagnostic confirmation following an elevated CBP in six studies. Three of four studies found that adding HBPM to an elevated CBP was also cost-effective. CONCLUSION: Existing evidence supports the cost-effectiveness of incorporating HBPM or ABPM after an initial CBP-based diagnosis of hypertension. Future research should focus on their implementation in clinical practice, long-term economic values, and potential roles in identifying masked hypertension.
Authors: Denis L Clement; Marc L De Buyzere; Dirk A De Bacquer; Peter W de Leeuw; Daniel A Duprez; Robert H Fagard; Peter J Gheeraert; Luc H Missault; Jacob J Braun; Roland O Six; Patricia Van Der Niepen; Eoin O'Brien Journal: N Engl J Med Date: 2003-06-12 Impact factor: 91.245
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Paula Lorgelly; Ilias Siatis; Andrew Brooks; Barbara Slinn; Michael W Millar-Craig; Richard Donnelly; Gillian Manning Journal: Br J Gen Pract Date: 2003-10 Impact factor: 5.386
Authors: Jan A Staessen; Elly Den Hond; Hilde Celis; Robert Fagard; Louis Keary; Guy Vandenhoven; Eoin T O'Brien Journal: JAMA Date: 2004-02-25 Impact factor: 56.272
Authors: Kate Lovibond; Sue Jowett; Pelham Barton; Mark Caulfield; Carl Heneghan; F D Richard Hobbs; James Hodgkinson; Jonathan Mant; Una Martin; Bryan Williams; David Wonderling; Richard J McManus Journal: Lancet Date: 2011-08-23 Impact factor: 79.321
Authors: Y Claire Wang; Daichi Shimbo; Paul Muntner; Andrew E Moran; Lawrence R Krakoff; Joseph E Schwartz Journal: Am J Epidemiol Date: 2017-02-01 Impact factor: 4.897
Authors: Shia T Kent; Daichi Shimbo; Lei Huang; Keith M Diaz; Anthony J Viera; Meredith Kilgore; Suzanne Oparil; Paul Muntner Journal: J Am Soc Hypertens Date: 2014-10-02
Authors: Alberto Mazza; Michela Armigliato; Maria Cristina Marzola; Laura Schiavon; Domenico Montemurro; Giorgio Vescovo; Marco Zuin; Sotirios Chondrogiannis; Roberta Ravenni; Giuseppe Opocher; Patrick M Colletti; Domenico Rubello Journal: Endocrine Date: 2013-07-02 Impact factor: 3.633